You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 133 No. 9, September 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (30)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology, Other
 •Surgical Oncology
 •Surgical Interventions, Other
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Alert me on articles by topic

Laparoscopic Cryoablation of Hepatic Metastases

David A. Iannitti, MD; B. Todd Heniford, MD; Jonathan Hale, MD; Sharon Grundfest-Broniatowski, MD; Michel Gagner, MD

Arch Surg. 1998;133:1011-1015.

Objective  To evaluate the feasibility of laparoscopic cryoablation for the management of hepatic metastases.

Design  Retrospective review.

Setting  Tertiary referral center.

Patients  Nine patients were evaluated by laparoscopy for planned laparoscopic cryoablation of hepatic metastases at The Cleveland Clinic Foundation, Cleveland, Ohio, from April 1996 to May 1997.

Results  Laparoscopic exploration revealed diffuse extrahepatic disease not identified by preoperative studies in 2 patients. The remaining 7 patients underwent 9 cryotherapy sessions. During 4 of the cryotherapy sessions, ultrasonography demonstrated unrecognized additional treatable hepatic lesions. An average of 3 lesions (range, 2-5) were treated. Operative time averaged 3.5 hours with a mean intraoperative blood loss of 235 mL. One patient had significant intraoperative hemorrhage requiring conversion to open hepatic resection for bleeding control. Eight of the 9 patients tolerated normal diets and ambulated independently on the first postoperative day. Following cryotherapy, 4 of the patients developed fever without an infectious source. One patient developed a postoperative bile leak requiring percutaneous biliary stenting. Postoperative hospital stay averaged 4.5 days (median, 4 days; range, 2-14 days). At a mean follow-up of 9 months, 4 of the 7 patients treated are alive without evidence of disease, 2 are alive with disease, and 1 patient with a pancreatic primary tumor has died of disease.

Conclusions  Laparoscopy with laparoscopic ultrasonography is a useful tool in evaluating patients with hepatic metastases. Laparoscopic cryoablation is feasible and may result in lower postoperative morbidity in patients receiving aggressive treatment for inoperable hepatic metastases.


From the Departments of General Surgery (Drs Iannitti, Heniford, and Grundfest-Broniatowski) and Radiology (Dr Hale), The Cleveland Clinic Foundation, Cleveland, Ohio; and Division of Laparoscopic Surgery, Mount Sinai Medical Center, New York, NY (Dr Gagner).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hand-Assisted Laparoscopic Liver Surgery
Antonetti et al.
Arch Surg 2002;137:407-412.
ABSTRACT | FULL TEXT  

Hepatic Radiofrequency Ablation
Iannitti et al.
Arch Surg 2002;137:422-427.
ABSTRACT | FULL TEXT  

Stereotactically Guided Laser Therapy of Occult Breast Tumors: Work-in-Progress Report
Dowlatshahi et al.
Arch Surg 2000;135:1345-1352.
ABSTRACT | FULL TEXT  

Sonographic Guidance of Laparoscopic Renal Cryoablation
Remer et al.
Am. J. Roentgenol. 2000;174:1595-1596.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.